The State of Recovery Technology in 2026
Digital therapeutics survived Pear's bankruptcy. AI onboarding is here. Telehealth MAT is permanent. What works and what doesn't.
Body: [Draft covers: the digital therapeutic reset after Pear Therapeutics’ 2023 bankruptcy; the renaissance of behavioral health VC with mega-rounds (Talkiatry $210M, Grow Therapy $150M, Salma $80M); addiction-specific raises (Pelago $58M Series C, Boulder Care $35M, Quit Genius $14.7M); the investor shift toward outcomes and Medicaid populations; the permanent telehealth MAT rule as category tailwind; and what’s next — AI for relapse risk, personalized matching, crisis detection. Honest take: the space is maturing away from “wellness apps” toward accountable care.]
Related: Pelago, Boulder, Workit, Ophelia — who’s who in digital recovery | Pear Therapeutics bankruptcy — what the field learned | The permanent telehealth MAT rule, explained.
Sources Cited
- 01.Bhttps://rockhealth.com/insightsRock Health
- 02.Chttps://bhbusiness.comBehavioral Health Business
Filed Under
MAT — BuprenorphinePeer-Reviewed Research
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
Eli Lilly Just Paid $3.8 Billion to Bet That Depression's Next Blockbuster Looks Like DMT
Eli Lilly's up-to-$3.8 billion acquisition of AtaiBeckley, weeks after FDA finalized psychedelic clinical trial guidance, signals mainstream pharma is done waiting on the sidelines of psychedelic medicine.
Technology & InnovationLilly's $3.8B Psychedelic Bet Skips Past the People Who Need It Most
Eli Lilly's $3.8B AtaiBeckley acquisition is the largest Big Pharma bet on psychedelics yet — but the money is chasing a depression drug, not addiction treatment, and the medicalization it represents is a different animal from the peer-support culture that built this field.
Technology & InnovationDigital Health Just Raised $7.4 Billion. Addiction Treatment Barely Shows Up in the Count.
Rock Health's H1 2026 report shows $7.4B in digital health funding, concentrated in mega-deals for mental health. Addiction-specific treatment isn't named among them.